RESEARCH TRIANGLE PARK, N.C. – November 6, 2006 – Quintiles Transnational Corp. today announced that Paula Brown Stafford, Executive Vice President, Global Data Management, has been elected to the Board of Directors of CDISC, an industry consortium that leads the development of data standards to improve medical research.
CDISC, the Clinical Data Interchange Standards Consortium, is an open, multidisciplinary non-profit organization that has established worldwide industry standards to support the electronic acquisition, exchange, submission and archiving of clinical trial data and meta-data for medical and biopharmaceutical product development. The CDISC board sets strategic direction for the organization.
“Pricing pressures are forcing the pharmaceutical industry to seek out partners for non-core activities, and CDISC is in the perfect position to implement industry standards for the management of patient data,” Stafford said. “I look forward to using my experience working with the leading pharma and biotech companies to assist CDISC in leading the industry to reduce or eliminate duplication of processes and systems and improve the efficiency of the drug development process.”
C. David Hardison, Ph.D., Vice President, Life Sciences, Science Applications International Corporation, and Chairman of the CDISC board, welcomed Stafford. “Paula’s wealth of experience in a global Contract Research Organization will be a valuable addition to this outstanding team. I am sure the board will benefit from her expertise in data management and biostatistics, and we’re very glad to have a representative of Quintiles, a founding member of CDISC.”
Stafford joined Quintiles in 1985 as a biostatistician and has held a number of positions of increasing responsibility within the company, including roles in project management in the U.S. and in Europe, business development, scientific operations and general management. She holds Bachelor of Science and Master of Public Health degrees from the University of North Carolina at Chapel Hill.
She is a member of the Board of Directors of Bio-Imaging Technologies, Inc., a publicly held provider of medical imaging management services for clinical research, and is a member of the Board of Visitors in the Department of Psychology, School of Medicine, at UNC-Chapel Hill.
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, information, financial partnering and commercialization for the pharmaceutical and biotechnology industries. With 16,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at www.quintiles.com.